Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.35 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1472630 | 1.00 | ALOX15 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL1628421 | 1.00 | ALOX15 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL29619766 | 1.00 | ALOX15 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL31412795 | 1.00 | ALOX15 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL16461955 | 0.89 | ALOX15 (0.42) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL16461953 | 0.89 | ALOX15 (0.42) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL10977628 | 0.89 | BTN3A1 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| SCHEMBL10977620 | 0.89 | BTN3A1 (0.38) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| Linalyl Acetate SCHEMBL15745424 | 0.86 | ALOX15 (0.52) | ALOX15GAAHIF1AEPAS1TRPC6 | |
| Linalyl Acetate SCHEMBL58028 | 0.86 | ALOX15 (0.52) | ALOX15GAAHIF1AEPAS1TRPC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118207042-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| WO-2024046952-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | NOVOZYMES A/S (DK) | 2024-03-07 | — | — | WO | claimed |
| US-20230340374-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| US-20230166230-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | GIVAUDAN SA (CH) | 2023-06-01 | — | — | US | claimed |
| EP-4157203-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | Givaudan SA (CH) | 2023-04-05 | — | — | EP | claimed |
| EP-4139041-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-03-01 | — | — | EP | claimed |
| EP-4120991-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | Givaudan SA (CH) | 2023-01-25 | — | — | EP | claimed |
| WO-2021239742-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | GIVAUDAN SA (CH) | 2021-12-02 | — | — | WO | claimed |
| WO-2021213930-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2021-10-28 | — | — | WO | claimed |
| WO-2021185736-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | GIVAUDAN SA (CH) | 2021-09-23 | — | — | WO | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4581114-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Novozymes A/S (DK) | 2025-07-09 | — | — | EP | disclosed |
| US-20100087351-A1 | Perfumes for Linear Citrus Release in Rinse-Off Systems | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-04-08 | — | — | US | disclosed |
| WO-2009027957-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-05 | — | — | WO | disclosed |
| US-20080176781-A1 | Perfumes for linear citrus release in rinse-off systems | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2008-07-24 | — | — | US | disclosed |
| EP-0131254-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED TETRAHYDROFURANES | L. GIVAUDAN & CIE Société Anonyme (CH) | 1988-05-25 | — | — | EP | disclosed |
| EP-0131254-A2 | Process for the preparation of substituted tetrahydrofuranes | L. GIVAUDAN & CIE Société Anonyme (CH) | 1985-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALOX15 4169/4885GAA 2863/4885HIF1A 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.